This article reviews common gaps in Doctor of Nursing Practice (DNP) education, including variability in DNP project rigor, informatics/artificial intelligence skills, competency-based preparation, and scholarly writing. Standardized competency assessments for DNP projects are needed, along with robust faculty development.

Biologic medications provide opportunities to improve the health, safety, quality of life, and long-term outcomes of patients with moderate-to-severe uncontrolled asthma. This article provides primary care nurse practitioners with an overview of the pathophysiology of Type 2 inflammation in asthma, the mechanism of action of biologics approved for asthma, monitoring considerations, and practice considerations.

This article embarks on a journey through recent advances in postpartum depression (PPD), specifically focusing on rapid-acting neuroactive steroids, the first medications approved specifically for PPD.

Group A Streptococcus (GAS) pharyngitis remains the leading bacterial cause of acute sore throat worldwide. Surges in GAS infections are driven by hypervirulent strains such as M1UK. The 2025 clinical practice guideline update from the Infectious Diseases Society of America introduces evidence-based recommendations for risk assessment using clinical scoring systems to optimize diagnostic testing and reduce unnecessary antibiotic use. This review examines current diagnostic approaches, treatment protocols, antimicrobial resistance patterns, and emerging therapeutic strategies to support nurse practitioners in delivering evidence-based, stewardship-aligned patient care.

Asthma is a chronic disease that persists into adulthood. Despite available treatments, many adults have poor symptom control. This article reviews the diagnosis of asthma and outlines current Global Initiative for Asthma recommendations for preferred and alternative pharmacologic management of mild-to-moderate asthma in adults.